A comparison study of Dutch and Norwegian Myasthenia Gravis patients: epidemiological and clinical aspects.

A comparison study of Dutch and Norwegian Myasthenia Gravis patients: epidemiological and clinical aspects. - FIGHT-MG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35739

Enrollment

500

Registered

2011-09-30

Start date

2011-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle disease serious muscle weakness

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: criteria 1 and 2 or 1 and 3 have to be fulfilled 1. Clinical weakness compatible with a from of myasthenia 2. Electromyographic evicence consistent with a neuromuscular transmission defect 3. Elevated serum antibody levels against ACHR, MuSK or VGCC

Exclusion criteria

Exclusion criteria: Age of

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: Primary endpoint: Comparison of potential predisposing and modifying factors between Dutch and Norwegian MG patients. .	—

Secondary

Measure	Time frame
Secondary endpoint: Comparison of demography, quality of life and differences in medical treatment between Dutch MG patients and Norwegian MG patients	—

Countries

Netherlands

Outcome results